Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35973985.
- Also identified by DOI 10.1038/s41467-022-32554-z and PMC identifier 9381774.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Early antiretroviral therapy (ART) in HIV-infected infants generally fails to achieve a sustained state of ART-free virologic remission, even after years of treatment. Our studies show that viral reservoir seeding is different in neonatal macaques intravenously exposed to SIV at birth, in contrast to adults. Furthermore, one month of ART including an integrase inhibitor, initiated at day 3, but not day 4 or 5 post infection, efficiently and rapidly suppresses viremia to undetectable levels. Intervention initiated at day 3 post infection and continued for 9 months achieves a sustained virologic remission in 4 of 5 infants. Collectively, an early intervention strategy within a key timeframe and regimen may result in viral remission or successful post-exposure prophylaxis for neonatal SIV infection, which may be clinically relevant for optimizing treatment strategies for HIV-infected or exposed infants.
Medical subject headings
- HIV Infections
- Simian Acquired Immunodeficiency Syndrome
- Simian Immunodeficiency Virus